Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAM17 | P78536 | 10/20 | 0.71 |
| ▸ | MMP13 | P45452 | 3/20 | 0.71 |
| ▸ | MMP2 | P08253 | 5/20 | 0.64 |
| ▸ | MMP9 | P14780 | 2/20 | 0.60 |
| ▸ | MMP12 | P39900 | 2/20 | 0.58 |
| ▸ | MMP3 | P08254 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6322236 | 0.94 | ADAM17 (0.68) | ADAM17MMP13MMP2MMP9MMP12 | |
| SCHEMBL6321457 | 0.90 | ADAM17 (0.74) | ADAM17MMP13MMP2MMP12MMP3 | |
| SCHEMBL3964556 | 0.84 | ADAM17 (0.69) | ADAM17MMP13MMP2MMP12MMP3 | |
| SCHEMBL6321024 | 0.83 | ADAM17 (1.00) | ADAM17MMP13MMP2MMP9 | |
| SCHEMBL6322313 | 0.82 | ADAM17 (0.69) | ADAM17MMP13MMP2MMP12MMP3 | |
| SCHEMBL6321972 | 0.81 | ADAM17 (0.67) | ADAM17MMP13MMP2MMP12MMP3 | |
| SCHEMBL6321967 | 0.81 | ADAM17 (0.67) | ADAM17MMP13MMP2MMP12MMP3 | |
| SCHEMBL3974118 | 0.81 | ADAM17 (0.67) | ADAM17MMP13 | |
| SCHEMBL3968857 | 0.80 | MMP2 (0.80) | ADAM17MMP2MMP12MMP3 | |
| SCHEMBL4051662 | 0.77 | ADAM17 (0.78) | ADAM17MMP13MMP2MMP12MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6936620-B2 | Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases | BRISTOL MYERS SQUIBB COMPANY (US) | 2005-08-30 | — | — | US | claimed |